Endothelin‐converting enzyme‐1c promotes stem cell traits and aggressiveness in colorectal cancer cells
Open Access
- 1 December 2019
- journal article
- research article
- Published by Wiley in Molecular Oncology
- Vol. 14 (2) , 347-362
Abstract
Endothelin‐1 is a mitogenic peptide that activates several proliferation, survival, and invasiveness pathways. The effects of endothelin‐1 rely on its activation by endothelin‐converting enzyme‐1 (ECE1), which is expressed as four isoforms with different cytoplasmic N termini. Recently, isoform ECE1c has been suggested to have a role in cancer aggressiveness. The N terminus of ECE1c is phosphorylated by protein kinase CK2 (also known as casein kinase 2), and this enhances its stability and promotes invasiveness in colorectal cancer cells. However, it is not known how phosphorylation improves stability and why this is correlated with increased aggressiveness. We hypothesized that CK2 phosphorylation protects ECE1c from N‐terminal ubiquitination and, consequently, from proteasomal degradation. Here, we show that lysine 6 is the bona fide residue involved in ubiquitination of ECE1c and its mutation to arginine (ECE1cK6R) significantly impairs proteasomal degradation, thereby augmenting ECE1c stability, even in the presence of the CK2 inhibitor silmitasertib. Furthermore, colorectal cancer cells overexpressing ECE1cK6R displayed enhanced cancer stem cell (CSC) traits, including increased stemness gene expression, chemoresistance, self‐renewal, and colony formation and spheroid formation in vitro, as well as enhanced tumor growth and metastasis in vivo. These findings suggest that CK2‐dependent phosphorylation enhances ECE1c stability, promoting an increase in CSC‐like traits. Therefore, phospho‐ECE1c may be a biomarker of poor prognosis and a potential therapeutic target for colorectal cancer.Keywords
Funding Information
- Fondo Nacional de Desarrollo Científico y Tecnológico (1140345, 1150117, 1150624, 1160889, 1161219, 3180621)
This publication has 50 references indexed in Scilit:
- ABC Transporters in Cancer Stem Cells: Beyond ChemoresistanceInternational Journal of Molecular Sciences, 2017
- Blocking endothelin-1-receptor/β-catenin circuit sensitizes to chemotherapy in colorectal cancerCell Death & Differentiation, 2017
- A distinct role for Lgr5+ stem cells in primary and metastatic colon cancerNature, 2017
- Getting the Whole Picture: Lymphangitic CarcinomatosisThe American Journal of Medicine, 2015
- Colorectal cancerThe Lancet, 2014
- Epigenetic and genetic features of 24 colon cancer cell linesOncogenesis, 2013
- Endothelin receptor-A is required for the recruitment of antitumor T cells and modulates chemotherapy induction of cancer stem cellsCancer Biology & Therapy, 2013
- Ubiquitin: Same Molecule, Different Degradation PathwaysCell, 2010
- Crypt stem cells as the cells-of-origin of intestinal cancerNature, 2008
- Tcf3 is an integral component of the core regulatory circuitry of embryonic stem cellsGenes & Development, 2008